Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Beijing Biotech
National Institutes of Health Clinical Center (CC)
Filamon LTD
AstraZeneca
Hoffmann-La Roche
Cancer Research UK
Children's Oncology Group
Essen Biotech
Essen Biotech
Mayo Clinic
Degron Therapeutics Co.
Cancer Research UK
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Incyte Corporation
Hadassah Medical Organization
LigaChem Biosciences, Inc.
Washington University School of Medicine
Incyte Corporation
Jonsson Comprehensive Cancer Center
University of South Florida
Stanford University
Universidade Federal de Pernambuco
Aminex Therapeutics, Inc.
Washington University School of Medicine
NGM Biopharmaceuticals, Inc
Mayo Clinic
ABM Therapeutics Corporation
Memorial Sloan Kettering Cancer Center
UNICANCER
Sumitomo Pharma America, Inc.
Children's Oncology Group
Kaohsiung Medical University Chung-Ho Memorial Hospital
Hoffmann-La Roche
City of Hope Medical Center
Eastern Cooperative Oncology Group
Quadriga Biosciences, Inc.
Xennials Therapeutics Australia Pty Ltd
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Duke University
Health Clinics Limited
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
Hospices Civils de Lyon
Celgene
Canadian Cancer Trials Group
Southwest Hospital, China
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cambridge University Hospitals NHS Foundation Trust